During the past decade, Evangelisches Krankenhaus Essen-Werden conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evangelisches Krankenhaus Essen-Werden" #1 sponsor was "German CLL Study Group" with 2 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "University of Ulm" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "German Hodgkin's Lymphoma Study Group" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelisches Krankenhaus Essen-Werden" #1 collaborator was "EBMT Solid Tumors Working Party" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Sunesis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Evangelisches Krankenhaus Essen-Werden" are "Leukemia" (3 trials), "Lymphoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Acute Myeloid Leukemia (AML)" (1 trials). Many other conditions were trialed in "Evangelisches Krankenhaus Essen-Werden" in a lesser frequency.

Most popular intervention types in "Evangelisches Krankenhaus Essen-Werden" are "Drug" (12 trials), "Biological" (5 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "cytarabine" (3 trials), "etoposide" (3 trials), "filgrastim" (3 trials) and "peripheral blood stem cell transplantation" (3 trials). Other intervention names were less common.

The vast majority of trials in "Evangelisches Krankenhaus Essen-Werden" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Evangelisches Krankenhaus Essen-Werden". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Evangelisches Krankenhaus Essen-Werden, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Evangelisches Krankenhaus Essen-Werden, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".